OCP SA, Casablanca, and Spain’s Fertinagro Biotech S.L., announced today they have completed the acquisition by OCP, via a subsidiary, of 20 percent of Fertinagro’s shares by way of a capital increase. The two companies reached an agreement for the deal in June.
All regulatory approvals have been secured and the capital increase has been approved by Fertinagro’s shareholders.
As part of the transaction, the two companies have signed an intellectual property and know-how license agreement as well as a co-development agreement. OCP said this is in line with its strategy to boost innovation and offer customised fertility solutions to meet famers’ specific needs.